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Abstract
The aim of this study was to identify the genetic basis of a chorioretinal dystrophy with high myopia of unknown origin in a
child of a consanguineous marriage. The proband and ten family members of Iranian ancestry participated in this study.
Linkage analysis was carried out with DNA samples of the proband and her parents by using the Human SNP Array 6.0.
Whole exome sequencing (WES) was performed with the patients’ DNA. Specific sequence alterations within the
homozygous regions identified by whole exome sequencing were verified by Sanger sequencing. Upon genetic analysis, a
novel homozygous frameshift mutation was found in exon 42 of the COL18A1 gene in the patient. Both parents were
heterozygous for this sequence variation. Mutations in COL18A1 are known to cause Knobloch syndrome (KS). Retrospective
analysis of clinical records of the patient revealed surgical removal of a meningocele present at birth. The clinical features
shown by our patient were typical of KS with the exception of chorioretinal degeneration which is a rare manifestation. This
is the first case of KS reported in a family of Iranian ancestry. We identified a novel disease-causing (deletion) mutation in the
COL18A1 gene leading to a frameshift and premature stop codon in the last exon. The mutation was not present in SNP
databases and was also not found in 192 control individuals. Its localization within the endostatin domain implicates a
functional relevance of endostatin in KS. A combined approach of linkage analysis and WES led to a rapid identification of
the disease-causing mutation even though the clinical description was not completely clear at the beginning.
Citation: Haghighi A, Tiwari A, Piri N, Nu ¨rnberg G, Saleh-Gohari N, et al. (2014) Homozygosity Mapping and Whole Exome Sequencing Reveal a Novel
Homozygous COL18A1 Mutation Causing Knobloch Syndrome. PLoS ONE 9(11): e112747. doi:10.1371/journal.pone.0112747
Editor: Olaf Strauß, Eye Hospital, Charite ´, Germany
Received August 7, 2014; Accepted October 14, 2014; Published November 13, 2014
Copyright:  2014 Haghighi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that, for approved reasons, some access restrictions apply to the data underlying the findings. All relevant data are
within the paper and its Supporting Information files.
Funding: This study was undertaken as part of GENE-ME (a research initiative for investigation of inherited diseases from the Middle-East). This study was funded
by a grant from the Swiss National Science Foundation (Grant number: 320030_138507) to WB and JN and from Velux Stiftung, Switzerland to WB. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: berger@medgen.uzh.ch (MB); haghighimd@yahoo.com (Alireza Haghighi)
. These authors contributed equally to this work.
Introduction
Knobloch syndrome (MIM:267750) (KS) is a very rare
autosomal recessive developmental disorder. It is characterized
by vitreoretinal degeneration usually with recurrent retinal
detachment, retinitis pigmentosa-like features, lens subluxation,
congenital high myopia, macular abnormalities and occipital
encephalocele. The ocular features of the disease are similar to
Stickler syndrome with optically empty vitreous and severe
chorioretinal degeneration and high myopia, which is caused by
mutations in collagen genes [1,2].
Since its first introduction in 1971 by Knobloch and Layer,
more than 50 cases have been reported all over the world. A defect
in early cephalic neuroectodermal morphogenesis has also been
suggested [1]. From 1971 to 1994, three families were reported
from Hungary and the US, as well as a large Brazilian family with
a history of consanguinity [1,3,4], all supporting the autosomal
recessive inheritance of this condition. In 1996, homozygosity
mapping in the same Brazilian family with 11 affected individuals
assigned the KS gene to 21q22.3, close to the marker D21S17 [2].
Through a positional cloning approach, Sertie et al. showed that
mutations in COL18A1 are responsible for KS [5]. The gene is
transcribed by use of two promoters and alternative splicing of the
third exon [6]. The C-terminal part (183 amino acids), designated
endostatin, can be cleaved-off proteolytically [7]. Collagen XVIII,
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determining the retinal structure as well as closure of the neural
tube [5]. This protein is an essential component of the basement
membrane of the iris, vitreous and retina and its presence is critical
for normal eye development during embryogenesis. Collagen
XVIII also seems to play important functional roles in neuronal
cell migration and as a component of the basement membrane of
kidney as well as teeth development [8,9]. It has been shown in an
experimental model that collagen XVIII is also important for
maintaining capillary permeability in striated muscle [10].
Williams et al. reported a case of KS with bilateral renal
anomalies, which implies a role of collagen XVIII in kidney
physiology [11]. In 1998, Wilson et al. reported two siblings from
New Zealand and proposed a possible involvement of mesoderm
in morphogenesis as those patients had abnormal pulmonary
lymphatics [12]. Sniderman et al. reported a case with anterior
midline scalp defect reflecting further clinical variability in this
rare autosomal recessive syndrome [13].
Mutations in COL18A1 gene can lead to occipital encephalo-
cele and severe ocular alterations [14]. It was also shown that a
lack of either the short (NC1-303) or long isoform (NC1-728) of
collagen XVIII causes similar phenotypes, but patients lacking all
isoforms exhibit increasingly severe ocular alterations. This
suggests that both isoforms play critical roles in the maintenance
and organization of the human eye [14]. In 2003, Kliemann et al.
reported neuronal migration disorders in two Brazilian patients for
the first time [15]. This was followed by the report of a case with
persistent fetal vasculature and initiated the discussion of a possible
role of endostatin in vascular remodeling of the fetal eye [16]. In
two siblings with KS from France, one presented with mental
retardation and severe supratentorial CNS anomalies, and a
second fetus with severe brain malformations, complete vermian
agenesis, and mesencephalic hamartoma, suggested that either
endostatin or full-length collagen XVIII play a role in neuronal
migration, revealing that CNS anomalies in KS were more severe
than initially thought [17]. In addition, Knobloch syndrome was
found to be associated with acute lymphoblastic leukemia in an El
Salvadorian patient. The authors proposed that an increased risk
of cancer may be an endostatin associated effect and suggested
monitoring of KS cases with respect to leukemia or other cancers
[18].
Here, we report an Iranian family in which the proband was
initially diagnosed with congenital chorioretinal degeneration and
myopia. A combination of homozygosity mapping and whole
exome sequencing (WES) identified a novel mutation in COL18A1
and led to the diagnosis of Knobloch syndrome. This is the first
case of KS identified using such an approach. It is also the first KS
case found in a family of Iranian descent.
Materials and Methods
Enrollment of participants and clinical examinations
Recruitment of the family was based on interviews, question-
naires, and clinical examination of affected and unaffected
individuals by ophthalmologists and geneticists. An informed
written consent for clinical and molecular investigation was
obtained from all family members. The study was conducted in
accordance with the Helsinki Declaration. The approval for
genetic testing was awarded to The Institute of Medical Molecular
Genetics by the Federal Office of Public Health (FOPH) in
Switzerland. Complete ophthalmic examination was performed.
Visual acuity was measured using the Snellen chart. Ophthalmo-
logical exam was performed using the slit lamp biomicroscope,
indirect biomicroscopy and indirect ophthalmoscopy. Intraocular
pressure was measured by the Goldman tonometer. Flash ERG
was performed to evaluate the overall photoreceptor function.
DNA extraction
Peripheral blood samples were collected from all family
members. DNA was extracted using QIAamp DNA blood Midi
kits (Qiagen, Hilden, Germany).
Genotyping and linkage analysis
Whole genome genotyping for the proband and her parents was
carried out using the Genome-Wide Human SNP Array 6.0
(Affymetrix, Santa Clara, CA). Data were analyzed using the
program Graphical Representation of Relationships (GRR) [19].
Linkage analysis was performed assuming autosomal recessive
inheritance, full penetrance, consanguinity and a mutation carrier
frequency of 0.0001. Multipoint LOD scores were calculated using
the program ALLEGRO [20]. All data handling was done using
the graphical user interface ALOHOMORA [21]. Homozygous
genomic regions restricted to the patient and absent in her parents
were identified and a tab-delimited ‘‘regions of interest’’ file was
generated.
Whole exome sequencing analysis
Whole exome sequencing was performed using NimbleGen
SeqCap EZ Human Exome Library (Roche NimbleGen Inc.,
Madison, WI) for library preparation and paired-end 100 nt
sequencing on Illumina HiSeq Alignment of sequence reads,
indexing of the reference genome, variant calling and annotation
was done with a pipeline based on BWA [22], Samtools [23],
Picard and Annovar [24]. Variants were annotated using Alamut-
HT (Interactive Biosoftware, Rouen, France) and filtered against
the above described regions of interest file in order to obtain
variants within homozygous regions specific to the patient.
Variants were visualized on Alamut Viewer 2.2 (Interactive
Biosoftware, Rouen, France). A filtering pipeline was established
to remove known SNPs or benign polymorphisms. The following
variants passed the filter: (a) non-annotated novel SNPs (b) variants
with minor allele frequency #0.02 (c) variants with a SIFT score of
#0.05 (deleterious) as well as (d) variants with a MAPP
(Multivariate Analysis of Protein Polymorphism) -score (=bad or
unknown).
Primer design, PCR amplification and Sanger sequencing
Primers were designed using Primer3 software [25] and
purchased at Microsynth AG (Balgach, Switzerland). Exon 42 of
COL18A1 was amplified in duplicate from genomic DNA of the
patient and available family members using Hot FirePol DNA
Polymerase (Solis BioDyne, Tartu, Estonia) and the following
primers: forward 59-GTGTCTGGCAGAAGCAGCAT-39 and
reverse 59-TCACAGGTCAGGGGAGAGTT-39. Sanger se-
quencing was performed using the Big Dye Terminator Cycle
v1.1 Sequencing Kit (Applied Biosystems, Carlsbad, California,
USA) and ABI Prism 3730 Genetic Analyzer (Applied Biosystems,
Carlsbad, California, USA). 192 randomly collected DNAs from
the general population were used to assess the frequency of the
mutation. Sanger sequencing data was analyzed using SeqScape
v2.6 (Applied Biosystems, Carlsbad, California, USA).
Results
Clinical Description
The female proband (IV-1, Figure 1a) was examined at 10 years
of age. She initially presented at eight months of age with deviation
and involuntary eye movements. On physical examination, at the
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segment oculus uterque (both eyes, OU) [specifically speaking iris
was normal OU and after pupillary dilation there was no
abnormality in lens periphery OU]. Cycloplegic refraction
revealed highly myopic refractive error OU (216.00 D). Dilated
fundus examination showed waxy optic discs (Figure 1c-white
arrow) with a cup-to-disc ratio of 0.1, arterial narrowing
(Figure 1b-white arrow) and a diffuse chorioretinal atrophy with
a well-defined central atrophic lesion in the center of the macula
OU (Figure 1c-arrowhead).
Her parents were first cousins and there was no history of any
similar condition in the family, apart from the high myopia in two
of the aunts (III-10: 28.00 D, OU with myopic chorioretinal
atrophy and III-11: 216.00 D: OD; 29.50–2.00685u:OS with
high myopic chorioretinal atrophy) (Figure 1a).
Flash electroretinography (ERG), demonstrated severely dimin-
ished amplitude of a and b waves OU which was in favor of both
cone and rod dysfunction (Figure 1d).
Based on clinical findings differential diagnosis included the
following:
1. Congenital-onset central chorioretinal dystrophy associated
with high myopia [26], this has been reported in a family in
middle east without genotyping; however ocular features are
very similar to our patient
2. Leber’s congenital amaurosis type with central macular
atrophy (NMNAT1 mutation) [27]. Ocular findings of this
type of leber’s is also very similar to what we saw in our patient
Eye glasses were prescribed for the patient and she was then
followed up somewhere else for seven years. At 8 years of age, her
physical and intellectual developments were normal. At school, she
maintained good academic standing, with the assistance of low-
vision aids such as magnifiers or magnified prints. On ophthalmic
examination, nystagmus was apparent. The best corrected visual
acuity (BCVA) was 20/400 OU and the refractive error was 2
12.50 D, OU. Dilated fundus examination was remarkable for
waxy optic nerve with a cup-to-disc ratio of 0.1, arterial narrowing
and diffuse chorioretinal atrophy (myopic changes) with a well-
defined central atrophic lesion with prominent underlying large
choroidal vessels. The clinical findings were the same as seven
years ago.
A few months later, she presented with a chief complaint of
visual field defect in the left eye for a few days. Fundus
examination revealed a superonasal retinal detachment. She
underwent 23-gauge pars plana vitrectomy (PPV) and silicone oil
injection. After 2 months, she developed cataract (as a conse-
quence of vitrectomy surgery); however, the retina was flat.
Cataract surgery and posterior chamber intraocular lens implan-
tation (PC IOL) were performed accompanied with removal of
silicone oil through a separate scleral incision. BCVA after the
surgery was 20/400. Two years later, she developed posterior
capsule opacity, which required YAG laser capsulotomy to restore
the vision.
Ophthalmic examination of the parents was unremarkable with
normal vision and extraocular movements, and normal anterior
and posterior segments. The proband’s two aunts (III-10 and III-
11, Figure 1a) had high myopia OU. Anterior segments were
normal OU. Fundus examination revealed chorioretinal atrophy
(myopic changes) without unusual findings.
Genetic Analysis
Genotyping and linkage analysis. Genome-wide genotyp-
ing of the patient-parent-trio with a high-density SNP array
identified19 homozygous regions that were unique to the proband
and not observed in her parents (table S1, figure S1). The LOD
(logarithm of odds) scores obtained for these homozygous regions
were not higher than 1.8 (figure S1) as expected for a trio with
consanguineous marriage.
Whole Exome Sequencing. In total, 8.87 Gb of data were
obtained upon sequencing that constituted about 9.5*10
7 reads.
While mean coverage was 98x, 97% of sequences had at least 10-
times coverage and 90% of the sequences were covered at least 30-
times. 38276 variants were obtained from the whole-exome
sequencing of the patient’s DNA and alignment to the reference
sequence. Using the ‘‘regions of interest’’ file (see Materials and
Methods), variants were annotated by using Alamut-HT. 2327
variants were obtained in the homozygosity regions of interest with
219 of them being novel (not annotated in dbSNP). Almost one-
fifth of the variants were missense mutations, 114 of them
predicted to be damaging. Table 1 lists the distribution of the
sequence variations. We subjected the 2327 variants to our
filtering pipeline (described in Materials and Methods) and found a
novel deletion in COL18A1: NM_130445.2:c.3825_3838del:p.-
Ser1276Alafs*9. This 14 bp deletion is predicted to cause a
frameshift at a highly conserved Serine residue at position 1276
(Figure 2) and results in a stop codon 9 triplets downstream.
Snapshots of Alamut Viewer 2.2 in figure 2 show the bidirectional
coverage of the sequencing reads where a deletion in exon 42 of
COL18A1 gene can be clearly seen (upper panel). The deletion is
also predicted to lead to strong loss of multiple exonic splicing
enhancers (Figure 2, lower panel).
Segregation Analysis. The family of the proband spanned
four generations and comprises 19 family members. The parents
of the index patient were first cousins. The proband and ten other
family members were involved in this study (Figure 1a). Subjects
were genotyped by direct Sanger sequencing of the mutation in
COL18A1 (NM_130445.2:c.3825_3838del:p.Ser1276Alafs*9).
Sanger sequencing confirmed the exome sequencing results that
the proband (IV-1, Figure 1a) was homozygous for this mutation
(Figure 2 and 3a). Parents of the proband (III-7 and III-8,
Figure 1a) were heterozygous for the same mutation (Figure 3a),
so were two uncles (III-3 and III-4) and two aunts (III-5 and III-11)
(data not shown). Three uncles (III-6, III-9 and III-12, Figure 1a)
and one aunt (III-10, Figure 1a) did not carry this mutation (data
not shown). This frameshift deletion cosegregated with the
phenotype in the family as an autosomal recessive trait as expected
for Knobloch syndrome. The mutation was absent in control
DNA samples of Caucasian origin from 192 unrelated individuals
tested for this mutation (data not shown). Controls from Iranian
descent were not available. Two of the aunts (III-10 and III-11,
Figure 1a) also showed high myopia but this condition did not
cosegregate with the identified COL18A1 frameshift deletion. III-
10 was homozygous for the reference allele and III-11 was
heterozygous for the mutation but both had high-grade myopia.
Discussion
The proband is the first case of Knobloch syndrome in a family
of Iranian descent. Twenty mutations leading to KS have been
described in the COL18A1 gene. This includes 5 missense
mutations [12,14,15,28–30], 3 mutations affecting correct splicing
[5,17,31], 5 small deletions [14,28,31,32], 4 small insertions
[14,28,31,33], 2 gross deletions [28,29,31] and 1 small indel [29]
(Source: HGMD Professional 2014.2).
Since the patient was an offspring of a first cousin marriage, we
employed a combined approach of homozygosity mapping and
whole exome sequencing and identified the disease-causing
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PLOS ONE | www.plosone.org 3 November 2014 | Volume 9 | Issue 11 | e112747Figure 1. a. Pedigree of a consanguineous family initially diagnosed with chorioretinal degeneration and high myopia (in some family members). b.
Color fundus photo OD shows the diffuse chorioretinal atrophy (white arrow points to the arterial narrowing). c. Color fundus photo OS showing the
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to that required by conventional analysis. By filtering the exome
data with our filtering pipeline (described in Materials and
Methods), only a single sequence variant in the COL18A1 gene
remained as a mutation candidate associated with the disease.
The patient was initially clinically characterized with congen-
ital-onset central chorioretinal dystrophy and myopia. Since we
found a mutation in COL18A1, a gene that had been previously
associated with Knobloch syndrome, we reanalyzed the clinical
data in depth. Retrospective evaluation of additional clinical data
upon identification of the mutation in COL18A1 revealed that the
patient had a meningocele surgically removed at 6 weeks of age.
Thus the clinical picture of the patient is consistent with Knobloch
syndrome. Mutations in COL18A1 are specific to Knobloch
Syndrome and no additional gene has been identified so far [29].
The phenotype includes retinal detachment, nystagmus and
congenital meningocele. While vitreoretinal degeneration is the
more common phenotype seen in KS patients, our patient showed
chorioretinal degeneration, a rather uncommon phenotype, which
has been previously reported by Mahajan et al. 2010 [18]. Two of
the family members of the patient had extreme myopia, which is a
phenotype frequently observed in KS patients. However, this did
not segregate with the COL18A1 mutation in the family.
The spectrum of ophthalmologic findings in KS was docu-
mented in a recent report by Khan et al [34] in eight patients. Six
of their patients had ectopia lentis, which was not seen in our case;
however their retinal findings are very similar to our case. We
suggest that in patients with congenital high myopia, retinitis
pigmentosa like chorioretinal atrophy and a well-defined atrophic
macular lesion, Knobloch syndrome should be considered as the
most likely diagnosis. It seems that anterior segment findings are
less consistent. These cases are at a high risk of retinal detachment
at young age and should be carefully observed.
Collagen XVIII is encoded by three isoforms, each differing in
their N-terminal regions. The mutation described in this study,
c.3825_3838del, causes a frameshift deletion in the last exon of
COL18A1, thus leading to an incomplete mRNA. This region of
COL18A1 also encodes for a cleavable protein called endostatin
that has been shown to be anti-angiogenic and inhibit tumor
formation [7]. The identified mutation causes loss of the terminal
60 amino acids of endostatin (Figure 3c, truncated amino acids are
highlighted in yellow). This immediately points to a role of
endostatin in the disease physiology of KS. Endostatin is encoded
by all isoforms of COL18A1, therefore, a mutation in the domain
containing endostatin will affect all isoforms of COL18A1.
Previous studies have shown a severe loss of endostatin levels in
KS patients [14,31]. Due to poor health condition of the proband,
we could not obtain additional samples for verifying her endostatin
levels.
Fukai et al. showed that mice lacking collagen XVIII/
endostatin manifest developmental eye defects, e.g. lack or
abnormal outgrowth of retina, delayed regression of blood vessels
in the vitreous along the surface of retina after birth and reduced
expression of VEGF (Vascular Endothelial Growth Factor) [35].
Persistent fetal vasculature is the other endostatin-deficiency
related condition in KS patients. Loss of endostatin or its
deficiency might cause delayed or reduced fetal blood vessel
regression in the eye. This can cause failure of normal vascular
development in the retina [16]. Endostatin physically interacts
with extracellular matrix components such as laminin-1, fibulin-1,
fibulin-2, fibronectin, heparin sulfate, nidogen-2 and perlecan
[16,31,36,37]. Mutations in collagen XVIII/endostatin that lead
to loss of the protein/protein function might thus cause changes in
the overall structural organization and stability of the extracellular
matrix. Therefore, phenotypic variations of mutations in collagen
XVIII could be either due to reorganization of the ECM
(structural changes) or through defects in angiogenesis during
eye development.
This study describes a novel KS-causing mutation in COL18A1.
Our results also suggest a role of endostatin in the physiopathology
of KS. In the genetic analysis of this case, even though the LOD
scores obtained upon linkage analysis were not significant
(Significance $3, figure S1), using the relatively small homozygous
regions, we were able to detect the disease-causing mutation upon
whole exome analysis. Identification of the mutation using this
combined approach can facilitate the confirmation of the clinical
diagnosis when the initial clinical picture is not fully clear. In our
case, the initial clinical diagnosis was congenital-onset central
waxy optic disc (white arrow) and the well-circumscribed macular atrophic lesion (arrowhead). d. Flash ERG OU demonstrates severely diminished
amplitudes of the a and b waves.
doi:10.1371/journal.pone.0112747.g001
Table 1. Classification of the type of homozygous variants obtained by linkage analysis and whole exome sequencing.
Type of sequence alteration SIFT prediction Number Annotated SNPs Novel variants
Nonsense (stop) mutation -2 2 0
Amino acid substitution damaging 114 82 28
Amino acid substitution tolerated 378 357 21
Silent mutation - 685 629 56
Intronic or UTR mutation - 1031 924 107
Frameshift deletion -4 3 1
Frameshift insertion -2 2 0
In-frame deletion -5 5 0
In-frame duplication -4 3 1
In-frame insertion -1 1 0
Upstream and downstream mutations - 101 96 5
doi:10.1371/journal.pone.0112747.t001
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in COL18A1 led to a retrospective clinical analysis upon which the
clinical diagnosis was confirmed to be Knobloch syndrome. With
different medical systems across the world and increased mobility
of human beings to different countries and geographical areas, a
complete clinical record is not always available to clinicians.
Molecular analysis tools such as that described is this study can
provide the necessary support for a precise clinical characteriza-
Figure 2. Coverage of sequencing reads in COL18A1 including a 14 bp deletion (NM_130445.2:c.3825_3838del:p.Ser1276Alafs*9
(Exon 42) as seen on Alamut Viewer 2.2.0 (Upper panel). A loss of multiple strong ESEs is predicted due to the deletion (Lower panel).
doi:10.1371/journal.pone.0112747.g002
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application of correct treatment and or medical care regimen. In
addition, this approach led to identification of the underlying
causative mutation using a fraction of the costs and time in
comparison to the conventional candidate gene approaches. Thus,
it presents a strong case for using a combined approach of linkage
analysis (homozygosity mapping) with exome sequencing for rapid
and cost-effective diagnosis of Mendelian diseases.
Supporting Information
Figure S1 Genome-wide linkage analysis: Parametric
linkage analysis of the family was performed with
Figure 3. a. Sanger sequencing of COL18A1 mutation NM_130445.2:c.3825_3838del:p.Ser1276Alafs*9 (Exon 42) comparing a wild type sequence
(top), homozygous deletion in index patient IV-1 (middle) and heterozygous deletion in father of the index patient (bottom). b. Conservation of the
deleted nucleotides across various species. c. Alignment of three isoforms of COL18A1 and endostatin. The highlighted region is deleted in patient IV-
1.
doi:10.1371/journal.pone.0112747.g003
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Array 6.0. LOD scores (y-axis) were calculated using ALLEGRO
and plotted against the genetic distance in cM (centi Morgan) on
the x-axis, which is used as a surrogate for the genomic position.
Chromosomes are concatenated from p-ter to q-ter from left to
right.
(TIF)
Table S1 Homozygous regions in patient IV-1 obtained
by linkage analysis and subtracting common homozy-
gous regions from parents.
(DOCX)
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